American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control: A call to action

Diabetes Care

Volumn 29, Issue 8, 2006, Pages 1955-1962

  Garber, Alan J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOSE; INSULIN;

ACUTE HEART INFARCTION; ALGORITHM; CLINICAL TRIAL; COLLEGE; CONFERENCE PAPER; DIABETES MELLITUS; DIET THERAPY; ENDOCRINOLOGY; ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE QUALITY; HEART SURGERY; HOSPITAL ORGANIZATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; MEDICAL PRACTICE; MEDICAL SOCIETY; META ANALYSIS; MORTALITY; PARENTERAL NUTRITION; PATIENT CARE; PATIENT EDUCATION; PATIENT SAFETY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WOUND INFECTION;

BLOOD GLUCOSE; DIABETES MELLITUS; ENDOCRINOLOGY; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; QUALITY OF HEALTH CARE; QUESTIONNAIRES; SOCIETIES, MEDICAL; TREATMENT OUTCOME; UNITED STATES;

EID: 33746653814     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-9913     Document Type: Conference Paper

References (47)

1. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, Saydah SH, Williams DE, Geiss LS, Gregg EW: Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 29:1263-1268, 2006
2. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE: Unrecognized diabetes among hospitalized patients. Diabetes Care 21:246-249, 1998
3. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE: Hyperglycemia: an independent marker of inhospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978-982, 2002
4. Centers for Disease Control and Prevention: National Diabetes Fact Sheet: general information and national estimates on diabetes in the United States, 2003 [article online], 2004. Available from www.cdc.gov/diabetes/pubs/factsheet. htm. Accessed 5 June 2006
5. Hogan P, Dall T, Nikolov P, the American Diabetes Association: Economic cost of diabetes in the US in 2002. Diabetes Care 26:917-932, 2003
6. Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V, the American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control: American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 10 (Suppl. 2):4-9, 2004
7. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB, the American Diabetes Association Diabetes in Hospitals Writing Committee: Management of diabetes and hyperglycemia in hospitals (Review). Diabetes Care 27:553-591, 2004 [errata in Diabetes Care 27:856, 2004 and Diabetes Care 27:1255, 2004]
8. American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 28 (Suppl. 1):S4-S36, 2005 [erratum in Diabetes Care 28:990, 2005]
9. Malmberg K, the DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group: Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 314:1512-1515, 1997
10. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67:352-362, 1999
11. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367, 2001
12. Furnary AP, Gao G, Grunkemeier GL,Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:1007-1021, 2003
13. Krinsley JS: Effect of intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79:992-1000, 2004 [erratum in Mayo Clin Proc 80:1101, 2005]
14. Pittas AG, Siegel RD, Lau J: Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized, controlled trials. Arch Intern Med 164:2005-2011, 2004
15. Malmberg K, Norhammar A, Wedel H, Ryden L: Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626-2632, 1999
16. Sala J, Masia R, Gonzalez de Molina FJ, Fernandez-Real JM, Gil M, Bosch D, Ricart W, Senti M, Marrugat J, the REGICOR Investigators: Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission. J Epidemiol Community Health 56:707-712, 2002
17. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS: The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 22:607-612, 2001
18. Ishihara M, Kojima S, Sakamoto T, Asada Y, Tei C, Kimura K, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Ikeda Y, Shirai M, Hiraoka H, Inoue T, Saito F, Ogawa H, the Japanese Acute Coronary Syndrome Study Investigators: Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 150:814-820, 2005
19. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-461, 2006
20. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM: Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111:3078-3086, 2005
21. Timmer JR, van der Horst IC, Ottervanger JP, Henriques JP, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F, the Zwolle Myocardial Infarction Study Group: Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 148:399-404, 2004
22. Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773-778, 2000
23. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenstrom A, the DIGAMI 2 Investigators: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26:650-661, 2005
24. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L, the CREATE-ECLA Trial Group Investigators: Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293:437-446, 2005
25. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL: Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 22:1408-1414, 1999
26. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR: Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 22:77-81, 1998
27. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32:2426-2432, 2001
28. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr: Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 75:1392-1399, 2003
29. Yendamuri S, Fulda GJ, Tinkoff GH: Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 55:33-38, 2003
30. Levetan CS, Salas JR, Wilets IF, Zumoff B: Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med 99:22-28, 1995
31. Furnary AP, Wu Y: Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. Endocr Pract 12 (Suppl. 3):22-26, 2006
32. Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE: Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 34:612-616, 2006
33. Newton CA, Young S: Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract 12 (Suppl. 3):43-48, 2006
34. Olson L, Muchmore J, Lawrence CB: The benefits of inpatient diabetes care: improving quality of care and the bottom line. Endocr Pract 12 (Suppl. 3):35-42, 2006
35. Hellman R: A systems approach to reducing errors in insulin therapy in the inpatient setting. Endocr Pract 10 (Suppl. 2):100-108, 2004
36. Smith WD, Winterstein AG, Johns T, Rosenberg E, Sauer BC: Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health-Syst Pharm 62:714-719, 2005
37. Buonocore D: Leadership in action: creating a change in practice. AACN Clin Issues 15:170-181, 2004
38. Ku SY, Sayre CA, Hirsch IB, Kelly JL: New insulin infusion protocol improves blood glucose control in hospitalized patients without increasing hypoglycemia. Jt Comm J Qual Patient Saf 31:141-147, 2005
39. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE: Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 27:461-467, 2004
40. Furnary AP, Wu Y, Bookin SO: Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 10 (Suppl. 2):21-33, 2004
41. Markovitz LJ, Wiechmann RJ, Harris N, Hayden V, Cooper J, Johnson G, Harelstad R, Calkins L, Braithwaite SS: Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract 8:10-18, 2002
42. Magee MF, Clement S: Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation. Endocr Pract 10 (Suppl. 2):81-88, 2004
43. Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, Ahmadi R, Nawaz H: Utility of HbA1c levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 26:1064-1068, 2003
44. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140-2144, 2002
45. Conaway DG, O'Keefe JH, Reid KJ, Spertus J: Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome. Am J Cardiol 96:363-365, 2005
46. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, Standl E, Soler-Soler J, Ohrvik J, the Euro Heart Survey Investigators: The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: the Euro Heart Survey on diabetes and the heart. Eur Heart J 25:1880-1890, 2004
47. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N: Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322:15-18, 2001